Cardiology and nephrology: Time for a more integrated approach to patient care?

European Heart Journal

Volumn 26, Issue 16, 2005, Pages 1576-1578

  Hobson, Alex ^a   Kalra, Philip A ^b   Kalra, Paul R ^c  

^a Wessex Cardiac Unit   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANGIOPLASTY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIALYSIS; ECHOCARDIOGRAPHY; EDITORIAL; HEART OUTPUT; HUMAN; KIDNEY TRANSPLANTATION; OXIDATIVE STRESS; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

ATHEROSCLEROSIS; CHRONIC DISEASE; HEART FAILURE, CONGESTIVE; HUMANS; PATIENT CARE; RENAL ARTERY OBSTRUCTION;

EID: 25844435214     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi375     Document Type: Editorial

References (10)

1. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-192.
2. Gurm HS, Lincoff AM, Kleiman NS, Kereiakes DJ, Tcheng JE, Aronow HD, Askari AT, Brennan DM, Topol EJ. Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. Am J Cardiol 2004;94:30-34.
3. Smilde TD, Hillege HL, Navis G, Boomsma F, de Zeeuw D, van Veldhuisen DJ. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J 2004;148:165-172.
4. Kalra PR, Bolger AP, Francis DP, Genth-Zotz S, Sharma R, Ponikowski PP, Poole-Wilson PA, Coats AJ, Anker SD. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol 2003;91:888-891.
5. Silverberg DS, Wexler D, Blum M, Wollman Y, Schwartz D, Sheps D, Keren G, Iaina A. The interaction between heart failure, renal failure and anemia - the cardio-renal anaemia syndrome. Blood Purif 2004;22:277-284.
6. de Silva R, Nitikin NP, Bhandari S, Nicholson A, Clark AL, Cleland JGF. Atherosclerotic renovascular disease in chronic heart failure: should we intervene? Eur Heart J 2005;26:1596-1605. First published on May 26, 2005, doi:10.1093/eurheartj/ehi304.
7. MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamotra H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998;352:13-16.
8. Wright JR, Shurrab AC, Cooper A, Foley RN, Kalra PA. The epidemiology of cardiac dysfunction in patients with atherosclerotic renovascular disease (ARVD). J Am Soc Nephrol 2003;14:673A.
9. Kalra PA, Guo H, Kausz AT, Gilbertson D, Liu J, Chen SC, Ishani A, Collins AJ, Foley RN. Atherosclerotic renovascular disease in US medicare recipients aged 67 years or more: risk factors, revascularization and prognosis. Kidney Int 2005;68:293-301.
10. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Sternbruch S, Iaina A. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000;35:1737-1744.